Brief: Seelos Therapeutics Inc - Received Letter From Nasdaq Notifying Co It Has Regained Full Compliance With Nasdaq Listing Rule
01/09/2022 21:56
Sept 1 (Reuters) - Seelos Therapeutics Inc SEEL.O :
* SEELOS THERAPEUTICS INC - RECEIVED LETTER FROM NASDAQ
NOTIFYING
CO IT HAS REGAINED FULL COMPLIANCE WITH NASDAQ LISTING RULE
Further company coverage: SEEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seelos Therapeutics
See all newsBrief: Seelos Therapeutics Commences Chapter 11 Proceedings- Court Filing
Brief: Seelos Therapeutics Announces Notice Of Delisting From Nasdaq And Transfer Of Listing To Over-The-Counter Market
Brief: Seelos Announces Postponement Of Its Annual Meeting Of Stockholders
Brief: Seelos Therapeutics Announces 1-For-16 Reverse Stock Split
U.S. STOCKS ON THE MOVE-Copper miners, Visa, Bluebird bio